19
Views
8
CrossRef citations to date
0
Altmetric
Research Article

Determination of Plasma Cell Secreting Potential as an Index of Maturity of Myelomatous Cells and a Strong Prognostic Factor

, , , , , , , , , , & show all
Pages 1605-1612 | Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Kyle D. Weaver, Stuart A. Grossman & James G. Herman. (2006) Methylated Tumor-Specific DNA as a Plasma Biomarker in Patients with Glioma. Cancer Investigation 24:1, pages 35-40.
Read now

Articles from other publishers (7)

Ariosto S. Silva & Robert A. Gatenby. (2011) Adaptation to Survival in Germinal Center Is the Initial Step in Onset of Indolent Stage of Multiple Myeloma. Molecular Pharmaceutics 8:6, pages 2012-2020.
Crossref
Judit Várkonyi, Edina Bajzik, Ádám Fazakas, Sándor Sipka & István Karádi. (2008) Short or Long Survival in Multiple Myeloma. A Simple Method for Determining the Prognosis. Pathology & Oncology Research 15:3, pages 383-387.
Crossref
Paolo Cascio, Laura Oliva, Fulvia Cerruti, Elisabetta Mariani, Elena Pasqualetto, Simone Cenci & Roberto Sitia. (2008) Dampening Ab responses using proteasome inhibitors followingin vivo B cell activation. European Journal of Immunology 38:3, pages 658-667.
Crossref
Simone Cenci & Roberto Sitia. (2007) Managing and exploiting stress in the antibody factory. FEBS Letters 581:19, pages 3652-3657.
Crossref
Simone Cenci, Alexandre Mezghrani, Paolo Cascio, Giada Bianchi, Fulvia Cerruti, Anna Fra, Hugues Lelouard, Silvia Masciarelli, Laura Mattioli, Laura Oliva, Andrea Orsi, Elena Pasqualetto, Philippe Pierre, Elena Ruffato, Luigina Tagliavacca & Roberto Sitia. (2006) Progressively impaired proteasomal capacity during terminal plasma cell differentiation. The EMBO Journal 25:5, pages 1104-1113.
Crossref
Kenneth F. Lyon. (2005) Gingivostomatitis. Veterinary Clinics of North America: Small Animal Practice 35:4, pages 891-911.
Crossref
. (2003) Current Awareness in Hematological Oncology. Hematological Oncology 21:1, pages 43-50.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.